10-Q · June 22, 2026
BIO-key International, Inc. reported its Q1 2026 results, revealing a revenue increase of 34% year-over-year to $2.14 million, primarily driven by a 24% rise in license fees and a 125% boost in hardware sales. Despite…
Earnings analysis · 10-Q
BKYI earnings analysis
Filed August 13, 2026 · Our reading of the company's report
The latest report
The extracted 10-Q text is limited primarily to controls, legal proceedings, and other-information disclosures and does not include the current-quarter financial statements or MD&A needed to assess revenue, margins,…
Read full summary
The extracted 10-Q text is limited primarily to controls, legal proceedings, and other-information disclosures and does not include the current-quarter financial statements or MD&A needed to assess revenue, margins, EPS, cash flow, or segment performance. Controls were deemed effective as of June 30, 2026, and no material internal-control changes were reported for the quarter. No quantitative guidance was provided, while the filing did not include a separate Item 1A risk-factor update.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Disclosure Controls Remained Effective
Management evaluated disclosure controls as of June 30, 2026 and concluded that the CEO and CFO considered them effective at a reasonable assurance level.
-
No Material Control Changes
The company reported that there were no changes during the quarter ended June 30, 2026 that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
What to watch
-
No Updated Risk-Factor Disclosure
Item 1A states that, as a smaller reporting company, BIO-key is not required to provide a separate risk-factor update in this filing. Investors are instead directed to the risks in the 2025 Form 10-K/A and other SEC disclosures.
-
Limited Financial Trend Disclosure
The extracted filing does not provide current-quarter revenue, EPS, cash-flow, balance-sheet, or segment figures, preventing confirmation of operating trends as of June 30, 2026.
Management's outlook
No quantitative outlook or explicit guidance was provided in the extracted 10-Q text; the filing directs investors to the 2025 Form 10-K/A and other SEC disclosures.
Earlier filings 4
10-K · June 12, 2026
BIO-key International, Inc. reported significant challenges in 2025, marked by a revenue decline of 14% year-over-year, leading to a net loss increasing to $7.16 million compared to $4.30 million in 2024. Strategic…
10-K · June 12, 2026
BIO-key International, Inc. reported a challenging year with decreasing revenues and increased net losses. Despite a strategic focus on expanding its identity access management solutions, the company faced substantial…
10-Q · August 13, 2025
BIO-key reported Q2 2025 revenue of $1,696,907, up 49% year-over-year driven by hardware (+581% to $568,824) and modest license growth (+4% to $806,087). Gross margin contracted to 73% (from 77% a year ago) and the…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.